Skip to main content
. 2014 Sep 5;2:33. doi: 10.1186/2049-2618-2-33

Table 3.

Comparison of PathoScope 2.0 against alternatives with ELISA negative fecal samples

 
STEC Genome/Plasmid Rank (Plasmid Rank)
Computation time (h:min)
Sample ID PathoScope 2.0
PathoScope 1.0
ReadScan
RINS
PathoScope 2.0 PathoScope 1.0 ReadScan RINS
Rank Proportion Rank Proportion Rank (Plasmid) Rank
1253
3
1.4%
8
0.3%
33 (2)
38
0:03
0:03
0:41
18:10
4961
7
0.3%
6
0.6%
40 (11)
38
1:16
0:59
1:09:37
23:58:39
1122
14
0.0%
2
7.3%
24 (1)
38
0:00
0:00
0:21:43
 
1196
NI
0.0%
2
3.0%
38 (1)
7
0:13
0:11
2:45:37
4:19:29
4096
25
0.0%
8
0.6%
70 (6)
14
0:07
0:06
0:29:09
0:06:00
1196b
4
0.8%
3
3.1%
31 (29)
9
0:04
0:04
1:27:27
7:03:26
4961b
8
0.2%
4
0.5%
35 (16)
39
0:15
0:12
0:30:49
21:30:20
1122b
15
0.0%
2
6.6%
26 (2)
38
0:03
0:02
0:17:41
5:32:59
4096b 22 0.0% 8 0.4% 76 (7) 36 0:01 0:01 0:14:37 0:18:45

NI: the STEC O104:H4 genome was not identified by the method.

These are the results from the O104:H4 study - Negative Samples. See the section titled ‘Evaluation and comparison on clinical sequencing samples’ for details.